Lenvatinib

CAS 417716-92-8 8 FDA-DMF suppliersSmall Molecule

Overview

Lenvatinib is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1289601).

API suppliers (3)

Suppliers of Lenvatinib backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

  • MSN Laboratories Private LimitedIndia3 active DMF
  • Dr. Reddy's Laboratories Ltd.India2 active DMF
  • OLON SPAItaly2 active DMF

Patent & exclusivity (US)

Per the FDA Orange Book (2 approved US products), the latest listed US patent on Lenvatinib expires 15 Nov 2038 and exclusivity 2 Oct 2027. Generic API sourcing typically opens up once these lapse.

Chemical identity

IUPAC name
4-[3-chloro-4-(cyclopropylcarbamoylamino)phenoxy]-7-methoxyquinoline-6-carboxamide
Canonical SMILES
COC1=CC2=NC=CC(=C2C=C1C(=O)N)OC3=CC(=C(C=C3)NC(=O)NC4CC4)Cl
InChIKey
WOSKHXYHFSIKNG-UHFFFAOYSA-N

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.

Start free trialBook a demo